БОРТЕЗОМІБ ШИЛПА
Analogs of БОРТЕЗОМІБ ШИЛПА
Find cheaper analogs and generic equivalents for БОРТЕЗОМІБ ШИЛПА.
Active Ingredient: Bortezomib
Product Overview
About БОРТЕЗОМІБ ШИЛПА
БОРТЕЗОМІБ ШИЛПА is a prescription medication containing the active ingredient Bortezomib, used in the treatment of multiple myeloma and mantle cell lymphoma. It is a proteasome inhibitor that works by blocking the action of proteasomes, which are complexes that break down proteins in cells.
Key Benefits & Uses
- Treatment of multiple myeloma, a type of blood cancer characterized by the proliferation of malignant plasma cells in the bone marrow.
- Treatment of mantle cell lymphoma, a rare and aggressive type of non-Hodgkin lymphoma.
- Indicated for patients who have received at least two prior therapies, including an immunomodulatory agent and a corticosteroid.
Active Ingredient & Action
Bortezomib, the active ingredient in БОРТЕЗОМІБ ШИЛПА, works by binding to the 26S proteasome, a complex that degrades ubiquitinated proteins. By inhibiting the proteasome, Bortezomib disrupts the normal functioning of cells, leading to cell cycle arrest and apoptosis (cell death). This mechanism of action makes Bortezomib an effective treatment for certain types of cancer.
Important Notes
БОРТЕЗОМІБ ШИЛПА is available in injectable form and should be administered by a healthcare professional. Patients should be closely monitored for signs of peripheral neuropathy, fatigue, and other adverse effects. It is essential to follow the recommended dosing schedule and to report any concerns or side effects to a healthcare provider promptly.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
